Teva Pharmaceutical TEVA
NYSE · Israel · Health Care
$39.60-0.21 (-0.53%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | 0.02 | 0.05 | -60.7% | $4.28B | +5.0% | +11.8%$31.67→$35.41 |
| Q1 2026 | 2026-04-29 | 0.50 | 0.49 | +2.0% | — | — | +10.9%$31.62→$35.07 |
| Q4 2025 | 2026-01-28 | 0.93 | 0.63 | +47.6% | — | — | +1.7%$32.53→$33.07 |
| Q3 2025 | 2025-11-05 | 0.75 | 0.66 | +13.6% | — | — | +19.6%$20.46→$24.46 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.